These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2987440)

  • 1. Prediction of survival in glioma patients by means of positron emission tomography.
    Patronas NJ; Di Chiro G; Kufta C; Bairamian D; Kornblith PL; Simon R; Larson SM
    J Neurosurg; 1985 Jun; 62(6):816-22. PubMed ID: 2987440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET as a prognostic factor in high-grade astrocytoma.
    De Witte O; Lefranc F; Levivier M; Salmon I; Brotchi J; Goldman S
    J Neurooncol; 2000 Sep; 49(2):157-63. PubMed ID: 11206011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
    Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
    Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
    Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
    J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
    Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
    No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
    Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
    Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
    Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
    Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors.
    Schifter T; Hoffman JM; Hanson MW; Boyko OB; Beam C; Paine S; Schold SC; Burger PC; Coleman RE
    J Comput Assist Tomogr; 1993; 17(4):509-61. PubMed ID: 8392523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
    Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
    Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET-FDG of pleomorphic xanthoastrocytoma.
    Bicik I; Raman R; Knightly JJ; Di Chiro G; Fulham MJ
    J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose.
    Kim CK; Alavi JB; Alavi A; Reivich M
    J Neurooncol; 1991 Feb; 10(1):85-91. PubMed ID: 2022975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
    Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
    J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of 13N-ammonia and 18F-FDG in the evaluation of untreated gliomas.
    Shi X; Liu Y; Zhang X; Yi C; Wang X; Chen Z; Zhang B
    Clin Nucl Med; 2013 Jul; 38(7):522-6. PubMed ID: 23698463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography.
    Kosuda S; Fujii H; Aoki S; Suzuki K; Tanaka Y; Nakamura O; Shitara N
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1201-6. PubMed ID: 7961030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced detection of brain tumors by [18F]fluorodeoxyglucose PET with glucose loading.
    Ishizu K; Sadato N; Yonekura Y; Nishizawa S; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Tanaka F; Miyatake S
    J Comput Assist Tomogr; 1994; 18(1):12-5. PubMed ID: 8282860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
    Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
    Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
    De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
    Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.